U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418203) titled 'Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination' on Feb. 06.
Brief Summary: Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Sante Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule.
Information, education and communication about HPV are essential to enable the entire population to make info...